Enfermedad de Parkinson: fisiopatología y nuevos tratamientos
National Institute for Health and Welfare
Helsinki, FinlandiaNational Institute for Health and Welfare-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2016
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Science Translational Medicine, Vol. 8, Núm. 341